2m 2m 2m 2m 2m 2m 2m
Biogen (BIIB)
NASDAQ
$217.38+$0.59 (+0.27%)
Price as of Aug 21, 2026 7:30 PM EDT- $32.0BMarket Cap
- 55.61%1-Year Change
- Drug Manufacturers - GeneralIndustry
Biogen (BIIB)
$217.38+$0.59 (+0.27%)
BIIB | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $216.78 | ||
Change | +$2.43 (+1.13%) | ||
Open | $217.76 | ||
High | $219.12 | ||
Low | $215.00 | ||
Previous Close | $214.35 | ||
Volume | 722,348 | ||
30-Day Average Volume | 947,294 | ||
1-Week Change | 3.31% | ||
1-Month Change | 6.70% | ||
1-Year Change | 55.61% | ||
3-Year Change | -18.22% | ||
5-Year Change | -36.57% | ||
Fundamentals | |||
Shares Outstanding | 147.8M | ||
Total Assets | $32.1B | ||
Market Cap | $32.0B | ||
Enterprise Value | $38.8B | ||
Period: QTR TTM FY | |||
Revenue | $1.9B | ||
Net Income | $97.5M | ||
Free Cash Flow | $408.0M | ||
EBIT | $214.7M | ||
EBITDA | $450.8M | ||
Net Working Capital | $3.4B | ||
EPS | $0.66 | ||
Enterprise Value/EBITDA | 86 | ||
Enterprise Value/Revenue | 20 | ||
P/B | 2 | ||
P/E | 328 | ||
PEG | -5 | ||
Price/Free Cash Flow | 79 | ||
Price/Operating Cash Flow | 71 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue